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Abstract
Background—Symptoms of posttraumatic stress disorder (PTSD) after acute coronary
syndrome (ACS) are associated with recurrent ACS events and mortality. Poor sleep may be a
mechanism, but the association between PTSD and sleep after ACS is unknown.
Purpose—To estimate the association between ACS-induced PTSD symptoms and self-reported
sleep.
Methods—ACS-induced PTSD symptoms were assessed 1-month post-ACS in 188 adults using
the Impact of Events Scale-Revised. Sleep was assessed using the Pittsburgh Sleep Quality Index.
Linear and logistic regression models were used to determine whether PTSD symptoms were
associated with self reported sleep, independent of sociodemographic and clinical covariates.
Results—In adjusted models, ACS-induced PTSD symptoms were associated with worse overall
sleep (β = 0.22, p = 0.003) and greater impairment in six of seven components of sleep (all p’s <
0.05).
Conclusions—ACS-induced PTSD symptoms may be associated with poor sleep, which may
explain why PTSD confers increased cardiovascular risk after ACS.
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Acute coronary syndrome (ACS)-induced symptoms of post-traumatic stress disorder
(PTSD) are prevalent among patients with ACS, and are associated with adverse clinical
outcomes. A recent meta-analysis of ACS patients found an aggregate prevalence estimate
for PTSD of 12% across 24 studies, and a doubling of risk for a combined outcome of
mortality and ACS recurrence in patients with clinically significant PTSD symptoms
compared to those without PTSD symptoms (1). It is well known that exposure to a
traumatic event can interfere with sleep and that PTSD contributes to the development of
sleep problems (2). Indeed, approximately 70% of people with clinician-diagnosed PTSD
have co-occurring sleep problems (2, 3). Additional research has shown that disrupted sleep
is also common among ACS patients (4), and disrupted sleep has been shown to predict
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cardiovascular outcomes (5). Understanding and modifying risk factors for disrupted sleep
in patients after ACS may ultimately reduce morbidity and mortality. Although risk factors
for disrupted sleep have been examined in patients with chronic diseases, including those
with stable coronary heart disease (6), few studies have examined predictors of sleep in post-
ACS patients.
Notwithstanding the wealth of data linking PTSD to sleep problems in the general
populations and psychiatric samples, no studies to our knowledge have examined the
specific association of ACS-induced PTSD symptoms with sleep in patients with an ACS.
Given that medically-induced forms of trauma such as an ACS have been differentiated
from other forms of trauma both conceptually and clinically (7), it is possible that the
associations of PTSD symptoms and sleep differ based on type of trauma. In addition, little
is known about the mechanisms linking PTSD to outcomes, and poor sleep may be a
candidate mechanism by which PTSD confers increased risk of ACS recurrence and
mortality. We thus examined the associations of ACS-induced PTSD symptoms with overall
self-reported sleep in a cross-sectional study of 188 patients with ACS. Given the well-
characterized association between PTSD and sleep reported in community samples and other
patient populations, we hypothesized that greater ACS-induced PTSD symptoms would be
associated with worse self-reported sleep. We secondarily tested whether pre-ACS history of
PTSD was also associated with overall self-reported sleep in this sample. Finally, we
examined whether specific components of self-reported sleep, including subjective sleep
quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of




Participants were consecutively hospitalized patients with ACS who were enrolled in the
Prescription Usage Lifestyle and Stress (PULSE) study, an ongoing, single site, prospective,
observational cohort study of the prognostic risk conferred by psychosocial factors at the
time of an ACS. Patients with unstable angina pectoris or acute ST and non-ST segment
elevation myocardial infarction were recruited from Columbia University Medical Center
within one week of hospitalization for their ACS. Patients completed a structured psychiatric
interview 3–7 days post-discharge and a follow-up interview 1 month later. The current
analyses include 188 participants who completed self-report measures of ACS-induced
PTSD symptoms and sleep approximately 1 month after their index ACS event. Excluded
from analyses were 507 participants who were enrolled prior to initiation of PTSD data
collection (n = 362), were missing data on sleep (n = 4), were missing data on both PTSD
symptoms and sleep (n = 94), or whose PTSD and sleep data were obtained beyond the
window of the 1-month follow-up visit (n = 47). Compared to the 188 participants included
in this study, the 507 participants not included did not differ on any sociodemographic,
behavioral, or clinical factors included in these analyses. Data collection occurred between
February 2009 and June 2010. The Institutional Review Board of Columbia University
approved this study, and all participants provided informed consent.
Measures
Self-Reported Sleep Problems—One-month following their discharge from the
hospital, participants attended a follow-up visit during which they completed the Pittsburgh
Sleep Quality Index (PSQI), a widely used self-report measure of sleep over the past month
on which higher total scores indicate worse overall sleep (8). Probable sleep disorder was
defined categorically as a global PSQI score > 5, a cutoff with diagnostic sensitivity of
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89.6% and specificity of 86.5% in distinguishing groups of “good” and “poor” sleepers
compared to gold standard clinical and laboratory measures (8).
In addition to a total sleep score, which has a possible range of 0 to 21, the PSQI also
provides information regarding seven components of sleep. The first component, subjective
sleep quality, is measured by a single item that asks participants to rate their overall sleep
quality using a 4-point response scale ranging from 1 (“very good”) to 4 (“very bad”). The
second component, sleep latency, is assessed with two items, including how many minutes it
usually takes the participant to fall asleep and how often participants are unable to fall asleep
within 30 minutes. For the second item, participants use a 4-point response scale ranging
from 1 (“not during the past month”) to 4 (“three or more times per week”). This 4-point
response scale is used for all other frequency items on the PSQI. The third component, sleep
duration, is based on the number of hours of sleep during a typical night reported by
participants. The fourth component, habitual sleep efficiency, is assessed using participants’
reports of when they typically went to bed, when they typically awoke, and how many hours
they typically slept. This information is used to compute the proportion of sleep time relative
to the number of hours in bed. The fifth component, sleep disturbance, is assessed using nine
items such as frequency of waking during the night or frequency of having pain. The sixth
component, use of sleep medications, is assessed based on participants’ reports of how often
they took prescription or over-the-counter medication to help them sleep. The seventh
component, daytime dysfunction, is assessed using two items that ask participants about the
frequency by which they were not able to “keep up enthusiasm to get things done” and
“having trouble staying awake while driving, eating meals, or engaging in social activity.”
Consistent with the PSQI scoring instructions (7) response to items for each PSQI
component were recoded such that scores ranged from 0 to 3, with higher scores indicating
poorer sleep on that component. Correlations (Spearman’s rho) among the individual sleep
components ranged from ρ = 0.11 (sleep duration and use of sleep medications) to ρ = 0.65
(sleep duration and habitual sleep efficiency). All correlations—except the associations of
use of sleep medications with sleep duration, daytime dysfunction, and habitual sleep
efficiency—were significant (all p’s ≤ 0.008). The mean correlation was ρ = 0.31.
Scores across the seven PSQI component scores were aggregated into a global score of self-
reported sleep with a range from 0 to 21. As global scores above 5 are considered indicative
of probable sleep disorder (8), any participant with a global score above 5 was given a score
of 1 on probable sleep disorder, and all other respondents were coded 0.
ACS-Induced PTSD Symptoms—ACS-induced PTSD symptoms were assessed at the
1-month follow-up visit with the Impact of Events Scale-Revised (IES-R) (9). Participants
used a 5-point scale ranging from 0 (“not at all”) to 4 (“extremely”) to report the extent to
which they had been bothered by each of 22 PTSD symptoms in the past week with
reference to their hospitalization for ACS. Specifically, they were told, “Think about when
you were hospitalized on [DATE], and we enrolled you in this study. In the past seven days
have you been bothered by any of the following in reference to that hospitalization?” The
IES-R yields a total score with a range from 0 to 88, and the internal validity of this score in
the current study was acceptable (Cronbach’s α = 0.94).
Pre-ACS History of PTSD—Within 3–7 days of their discharge from the hospital,
participants were screened for PTSD in the 3 months preceding hospitalization for their
index ACS event using the Structured Clinical Interview for DSM-IV (10). They reported
whether they had (1) experienced a traumatic event (“such as a major disaster, very serious
accident or fire, being physically assaulted or raped, seeing another person killed or dead, or
badly hurt, or hearing about something horrible that has just happened to someone close to
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you”), (2) whether the event recurred “in nightmares, flashbacks, or thoughts you cannot get
rid of,” and (3) whether the experience of “thoughts or feelings coming back” had happened
in the past 3 months. Participants who responded “yes” to all three items were categorized as
having a pre-ACS history of PTSD. Responses to these questions correctly identified 97% of
PTSD cases in previous studies (11). All analyses that included pre-ACS history of PTSD
were limited to the 158 participants who were not missing data on this variable.
Sociodemographic and Clinical Covariates—During their hospitalization,
participants identified their ethnicity (Hispanic versus non-Hispanic), race (Black versus
non-Black), high school education (yes/no), and partner status (has a partner or spouse/does
not have a partner or spouse). Medical chart review was used to ascertain body mass index
(BMI), prior cardiovascular disease and cardiac procedures (unstable angina, myocardial
infarction, percutaneous coronary intervention, coronary artery bypass grafting, New York
Heart Association heart failure class), prior cerebrovascular disease (stroke, transient
ischemic attack), and other chronic conditions (e.g., respiratory diseases, liver diseases, and
rheumatologic diseases). Age and sex were recorded for each participant. Measures of
disease severity included the Global Registry of Acute Coronary Events risk score as an
estimate of 6-month post-ACS mortality risk (12), and the Charlson comorbidity index as a
measure of medical comorbidities (13).
Psychological and Behavioral Covariates—During the 1-month follow-up,
participants also completed the 21-item Beck Depression Inventory (14) and the
Paffenbarger Physical Activity Questionnaire (15). The Beck Depression Inventory is a self-
report instrument that assesses severity of depressive symptoms experienced during the past
week, with possible scores for each question ranging from 0 to 3 and a possible total score
ranging from 0 to 63. It has excellent psychometric properties, as shown with multiple
community and medical samples (16). In the current study, the internal consistency of the
Beck Depression Inventory as measured by Cronbach’s α was 0.88. The Paffenbarger
Physical Activity Questionnaire was used to calculate weekly energy expended through
leisure time physical activity using the scoring system derived for this questionnaire, as
described by Paffenbarger and colleagues (17).
Analytic Strategy
Baseline sociodemographic, behavioral, and clinical characteristics were calculated
separately for those with and without probable sleep disorder, and participants in these two
groups were compared using independent-samples t-tests and Pearson’s chi-square tests for
continuous and categorical variables, respectively. The association between ACS-induced
PTSD symptoms and self-reported sleep was examined in an unadjusted and an adjusted
linear regression model with total IES-R score as the primary predictor and total continuous
PSQI score as the primary dependent variable. Given that the total PSQI score was
positively skewed, a square-root transformation was applied to this variable. The adjusted
linear regression model included sociodemographic, behavioral, and clinical predictors of
self-reported sleep (18) as covariates, including age, sex, partner status, high school
education, BMI, Paffenbarger physical activity score, GRACE risk score, Charlson
comorbidity index, and Beck Depression Inventory score. All covariates were entered with
the primary predictor variable in a single block. Similar unadjusted and adjusted binary
logistic regression models were conducted with probable sleep disorder (i.e., global PSQI
score > 5) as the outcome measure. To secondarily examine possible differential
associations between self-reported sleep and pre-ACS history of PTSD versus ACS-induced
PTSD symptoms, all aforementioned linear and logistic regression models were repeated
substituting pre-ACS history of PTSD for IES-R scores.
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To test whether specific components of self-reported sleep were associated with ACS-
induced PTSD symptoms, we conducted exploratory unadjusted and adjusted ordered
logistic regression models for each of the seven PSQI sleep components. The assumption of
proportional odds, which specifies homogeneity of the effect of each predictor variable
across all levels of the outcome, was evaluated for each model. This assumption was
violated for models with sleep duration, sleep efficiency, and sleep disturbances. Because
these three components of the PSQI are calculated using a continuous, interval scale before
being recoded to the continual, ordinal scale used by the other PSQI components, we
conducted a median split of these variables and analyzed them using binary logistic
regression.
We additionally performed exploratory analyses to characterize the unique and common
variance contributions of ACS-induced PTSD symptoms and depressive symptoms with
overall self-reported sleep. To do so, we conducted a hierarchical linear regression model
with three blocks of variables. Block 1 included age, sex, and all demographic and clinical
covariates except the Beck Depression Inventory; block 2 added the Beck Depression
Inventory; and block 3 added the IES-R. Using this approach, we report the change in the
variance explained in overall self-reported sleep associated with the addition of ACS-
induced PTSD symptoms to a model already including depressive symptoms. We
additionally report the partial correlations of ACS-induced PTSD symptoms with overall
self-reported sleep first controlling for all demographic and clinical covariates except
depressive symptoms and then additionally controlling for depressive symptoms.
The percentage of missing data on covariates ranged from 1.0% (for partner status) to 1.6%
(for Paffenbarger physical activity score). We applied multiple imputation generating five
imputed datasets. All variables except the primary independent variables (i.e., ACS-induced
PTSD symptoms and pre-ACS history of PTSD) and dependent variables (i.e., all PSQI
scores) were included. All analyses were conducted using SPSS 20.0 (IBM, Armonk, NY).
Results
Participants in this sample were predominantly male (65.4%) and non-Hispanic (63.8%)
with a mean age of 63.2 ± 11.3 years. Other descriptive characteristics of this sample are
shown in Table 1.
Association of ACS-induced PTSD symptoms with overall self-reported sleep
The mean IES-R score for the sample of 188 participants was 6.3 ± 11.0 (range: 0 – 55.0),
and the mean Global Registry of Acute Coronary Events total score was 5.2 ± 4.0 (range: 0
– 17.0). Greater ACS-induced PTSD symptoms were independently associated with worse
overall self-reported sleep in unadjusted and adjusted linear regression models. In the
adjusted model, which included as covariates age, sex, ethnicity, partner status, high school
education, BMI, Paffenbarger physical activity score, GRACE risk score, Charlson
comorbidity index, and depressive symptom score, each standard deviation increase on the
IES-R measure of ACS-induced PTSD symptoms was associated with a 0.22 standard
deviation worsening in overall self-reported sleep (β = 0.22, p = 0.003; Table 2). Hispanic
ethnicity, greater BMI, and depressive symptoms were also independent, significant
correlates of overall self-reported sleep in this adjusted linear regression model.
Of note, the unadjusted association of ACS-induced PTSD symptoms with overall self-
reported sleep was attenuated when depressive symptoms were added to the regression
model but not when other demographic and clinical characteristics were added. Specifically,
the zero-order correlation of ACS-induced PTSD symptoms with overall self-reported sleep
was 0.38; the partial correlation of ACS-induced PTSD symptoms with overall self-reported
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sleep independent of all covariates except depressive symptoms was 0.39; and the partial
correlation of ACS-induced PTSD symptoms with overall self-reported sleep independent of
all covariates including depressive symptoms was 0.26 (all p’s < 0.001). Notwithstanding
this attenuated effect, the addition of ACS-induced PTSD symptoms to a fully-adjusted
model that included depressive symptoms contributed to a significant increase of 5% in the
variance explained in overall self-reported sleep (Fchange (1, 172) = 12.5, p = 0.001).
Association of ACS-induced PTSD symptoms with probable sleep disorder
Of the 188 participants, 76 (40.4%) had a PSQI total score > 5, which is indicative of
probable sleep disorder. Compared to participants who did not have probable sleep disorder,
those who did have a probable sleep disorder had lower scores on the total PSQI score and
all seven sleep components, which is indicative of poorer self-reported sleep. They were also
significantly more likely to be female and Hispanic, had a significantly higher BMI, and
reported significantly more depressive symptoms and ACS-induced PTSD symptoms. In the
unadjusted logistic regression model, greater ACS-induced PTSD symptoms were
significantly associated with elevated odds of having probable sleep disorder (i.e., PSQI
total score > 5). Each point increase on the IES-R measure of ACS-induced PTSD
symptoms was significantly associated with approximately 6% increased odds of having
probable sleep disorder. ACS-induced PTSD symptoms were not significantly associated
with odds of probable sleep disorder in the adjusted model, although greater BMI and
greater depressive symptoms were significantly associated with increased odds of probable
sleep disorder in this model. Hispanic ethnicity was associated with significantly lower odds
of probable sleep disorder.
Association of pre-ACS history of PTSD with overall self-reported sleep and probable
sleep disorder
Pre-ACS history of PTSD was not associated with either overall self-reported sleep or
probable sleep disorder in unadjusted or adjusted regression models (all p’s > 0.11).
Association of ACS-induced PTSD symptoms with individual components of self-reported
sleep
Greater ACS-induced PTSD symptoms were significantly associated with six of seven PSQI
sleep components in unadjusted and adjusted logistic regression models (Table 3). The
association of ACS-induced PTSD symptoms with sleep latency was only significant in an
unadjusted model. The magnitude of the significantly increased odds of poor self-reported
sleep associated with each 1-point increase on the IES-R measure of ACS-induced PTSD
symptoms ranged from 2% for sleep quality and daytime dysfunction to 9% for sleep
disturbances. Female sex, Hispanic ethnicity, BMI, partner status, Charlson comorbidity
index, and depressive symptoms were also significantly associated with various self-
reported sleep components.
Discussion
We found that greater ACS-induced symptoms of PTSD were associated with worse overall
self-reported sleep and poorer scores on six of seven individual component of sleep as
measured by the PSQI in 188 patients with recent hospitalization for ACS. These
associations remained significant after adjusting for sociodemographic covariates, medical
comorbidities (Charlson), cardiac disease severity (Global Registry of Acute Coronary
Events risk score), and depressive symptoms (Beck Depression Inventory). We also
observed a trend for an association between ACS-induced PTSD symptoms and probable
sleep disorder, although this association did not remain significant after multivariable
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adjustment. In contrast, pre-ACS history of PTSD was not associated with overall self-
reported sleep or probable sleep disorder in either unadjusted or adjusted models.
Our findings are consistent with those from studies of PTSD and sleep among individuals
with PTSD induced by non-medical events. Indeed, previous studies have indicated that as
many as 70% of those with PTSD report sleep disturbances (3). Furthermore,
polysomnography assessments have shown that compared to those without exposure to
childhood trauma, those with exposure have greater trouble initiating and maintaining sleep,
poorer sleep quality, greater sleep disturbances and nighttime awakenings, lower sleep
efficiency, shorter duration of rapid eye movement sleep, and longer latency to enter rapid
eye movement sleep (2). Another study of outpatients with a primary diagnosis of PTSD
found positive correlations between severity of PTSD, the PSQI global score and five of the
seven PSQI components (sleep efficiency and use of sleeping medications did not vary with
PTSD severity) (19). The strong association between ACS-induced PTSD and sleep may be
due to the fact that disturbed sleep is embedded in the PTSD phenotype and its diagnosis.
However, results of recent treatment studies for PTSD and sleep disturbance suggest that the
two conditions may be most usefully conceptualized as comorbid, rather than one being
merely a symptom of the other (20, 21). In addition, autonomic dysregulation, which is
associated with both PTSD (22) and disrupted sleep (23), may represent a common
mechanism underlying their association.
Of note, the adjusted association of ACS-induced PTSD symptoms with probable sleep
disorder was not significant, although the magnitude of the unadjusted and adjusted
associations was comparable. Although it is possible that ACS-induced PTSD symptoms are
indeed not associated with probable sleep disorder, there are other explanations for the
observed null finding. First, we may have had limited statistical power to detect this
association given that our total sample size was small relative to the number of covariates in
our adjusted regression model. Second, it is possible that the cutpoint used to define
probable sleep disorder (i.e., PSQI total score > 5) is not optimal for participants with PTSD
or ACS-induced PTSD. Although the diagnostic accuracy of the PSQI has not been
investigated exclusively for individuals with PTSD to our knowledge, studies of other
measures have found different estimates of diagnostic accuracy for subgroups of patients
with different clinical characteristics (24). Interestingly, in post hoc analyses of this study,
we found that ACS-induced PTSD symptoms were significantly associated with an 8%
increased odds of probable sleep disorder in an adjusted model with probable sleep disorder
defined as having a PSQI total score greater than the median (> 4).
Our analyses identified several additional independent correlates of self-reported sleep and
sleep components including female sex, Hispanic ethnicity, partner status, BMI, Charlson
comorbidity index, and depressive symptoms. Consistent with several other studies, we
found that depressive symptoms were significantly associated with overall self-reported
sleep quality, probable sleep disorder, and some components of self-reported sleep (25–26).
Although the association of ACS-induced PTSD symptoms with overall self-reported sleep
was attenuated when controlling for depressive symptoms but not when controlling for other
demographic and clinical covariates, the addition of ACS-induced PTSD symptoms to a
fully-adjusted model with depressive symptoms contributed to a significant increase in the
variance explained in overall self-reported sleep. Future studies should further consider
reasons for the differential associations of depressive symptoms with various components of
self-reported sleep and disentangle the possibly complex associations among depression,
PTSD, and self-reported sleep in patients with ACS. We additionally observed that female
sex and greater BMI were associated with worse overall self-reported sleep, while Hispanic
ethnicity was associated with protective against various components of poor sleep. Although
the BMI finding is consistent with previous findings (27), other studies have reported no
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gender differences in objective and subjective sleep measures (28) and have suggested that
Hispanic ethnicity might confer increased risk for sleep problems (29). Future studies may
pursue a more detailed investigation of the association between sociodemographic factors
and sleep specifically in patients with ACS and other cardiovascular diseases.
Notwithstanding the strong and consistent associations observed between ACS-induced
PTSD symptoms and both overall self-reported sleep and specific sleep components, our
study is limited by several factors that deserve mention. First, it is cross-sectional,
precluding us from considering the directionality of the association between ACS-induced
PTSD and sleep. Although research in other populations suggests that exposure to a
traumatic event can interfere with sleep and that PTSD is related to the development of sleep
problems (2), other research has shown that poor sleep may contribute to the development of
PTSD (29). Future research with repeat assessments of sleep and PTSD are needed to
disentangle the possibly complex associations among these two factors in patients with
ACS. Secondly, our assessment of sleep was obtained by self-report at a single point in time.
Although the PSQI has been widely used in other studies, additional studies are needed with
assessments of objectively measured sleep via gold-standard methods such as
polysomnography. Future research should additionally consider whether sleep problems that
precede an ACS event or sleep problems at other time points following an ACS contribute to
the associations observed in the current study. Third, our assessment of ACS-induced PTSD
symptoms did not include a diagnostic interview. Although the IES-R has been widely
featured in studies of PTSD, has favorable psychometric properties (30), and has been linked
to prognosis in ACS patients (31), additional studies of the association between clinician-
diagnosed PTSD and sleep are needed. Fourth, we did not control for participants’ overall
medication use or a general measure of anxiety, which may confound the observed
associations of ACS-induced PTSD symptoms and self-reported sleep. Finally, very few
participants in our sample had a pre-ACS history of PTSD, which may have limited our
power to detect an association of this variable with self-reported sleep. Nonetheless, the
association of pre-ACS history of PTSD with each of the self-reported sleep outcomes was
uniformly non-significant, and we did not observe any signals of an association.
Conclusion
Our study is the first to examine the association of ACS-induced symptoms of PTSD with
self-reported sleep. The implications of the PTSD-sleep association in the context of the
post-ACS recovery period is thus important to consider with respect to gaining a better
understanding of the associations between PTSD, sleep, and cardiac prognosis as well as
treatment strategies for patients recovering from an ACS. Both poor sleep (5) and PTSD
symptoms (1) have been linked to adverse cardiovascular outcomes, and our findings
suggest that either sleep or PTSD may mediate or modify the impact of the other on cardiac
prognosis in ACS patients. If future research supports this mediation or moderation
hypothesis, then additional research might consider whether interventions that address either
PTSD symptoms or sleep among ACS patients offset the risk of adverse cardiovascular
events in this population. Still other research might consider the feasibility and efficacy of
routine screening for PTSD and sleep in patients with ACS to improve cardiovascular
outcomes—a policy that has recently been adopted with respect to other psychosocial risk
factors such depression in ACS (32).
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Table 1
Clinical and sociodemographic characteristics of 188 participants with acute coronary syndrome, by probable
sleep disorder
Study variable Full sample (N = 188) Probable sleep disorder(n = 76)
No probable sleep disorder
(n = 112) P
Overall self-reported sleep (PSQI total score) 5.2 (4.0) 9.3 (2.9) 2.5 (1.6) <0.001
 Sleep quality 0.9 (0.8) 1.5 (0.8) 0.5 (0.6) <0.001
 Sleep latency 0.9 (1.0) 1.6 (1.0) 0.4 (0.6) <0.001
 Sleep duration 0.9 (1.1) 1.6 (1.1) 0.4 (0.7) <0.001
 Sleep efficiency 0.7 (1.0) 1.4 (1.2) 0.3 (0.6) <0.001
 Sleep disturbances 0.9 (0.6) 1.3 (0.6) 0.6 (0.5) <0.001
 Use of sleep medications 0.5 (1.0) 1.1 (1.3) 0.1 (0.4) <0.001
 Daytime dysfunction 0.5 (0.7) 0.9 (0.8) 0.2 (0.4) <0.001
Sociodemographic factors
 Age, years 63.2 (11.3) 63.9 (10.4) 62.8 (12.0) 0.50
 Female, n (%) 65 (34.6) 34 (44.7) 31 (27.7) 0.016
 Hispanic ethnicity, n (%) 68 (36.2) 20 (26.3) 48 (42.9) 0.021
 Has a partner or spouse, n (%) 111 (59.0) 44 (58.7) 67 (59.8) 0.88
 Has a high school education, n (%) 137 (72.9) 56 (73.7) 81 (72.3) 0.84
Clinical and psychosocial factors
 Body mass index, kg/m2 29.3 (6.1) 30.7 (6.5) 28.4 (5.7) 0.013
 Paffenbarger physical activity score 974.5 (1,372.8) 846.1 (1,325.8) 1,061.6 (1401.8) 0.29
 GRACE risk score 89.2 (27.7) 92.7 (29.2) 86.8 (26.4) 0.15
 Charlson comorbidity index 1.6 (1.6) 1.8 (1.5) 1.5 (1.6) 0.14
 BDI depressive symptom score 6.5 (7.1) 10.6 (8.5) 3.7 (4.2) <0.001
 ACS-induced PTSD symptoms 6.3 (11.0) 10.0 (14.4) 3.8 (6.8) <0.001
 Pre-ACS history of PTSD, n (%) 9 (4.8) 4 (6.2) 5 (5.3) 0.80
Values are mean (standard deviation) unless otherwise specified. Probable sleep disorder was defined as a PSQI total score > 5.
Abbreviations. PSQI, Pittsburgh Sleep Quality Index; GRACE, Global Registry of Acute Coronary Events; ACS, acute coronary syndrome; BDI,
Beck Depression Inventory; PTSD; posttraumatic stress disorder
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